These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 15816454)

  • 1. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
    Yamamoto S; Akasu T; Fujita S; Moriya Y
    Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
    Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
    Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
    Veingerl B
    Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
    J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M; Gerstlauer C; Grimm M; Bueter M; Lebedeva T; Lutz J; Maeder U; Ribas C; Ribas C; Nichiporuk E; Thalheimer A; Heemann U; Thiede A; Meyer D; Waaga-Gasser AM
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does serum carcinoembryonic antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III.
    Hara M; Sato M; Takahashi H; Takayama S; Takeyama H
    J Surg Oncol; 2010 Aug; 102(2):154-7. PubMed ID: 20648586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
    Park JY; Lee KH
    Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer.
    Sadahiro S; Suzuki T; Maeda Y; Yurimoto S; Yasuda S; Makuuchi H; Kamijo A; Murayama C
    Ann Surg Oncol; 2007 Mar; 14(3):1092-8. PubMed ID: 17200912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patient compliance and efficacy of diagnostic procedures in the surveillance of colorectal cancer: experience from a cancer center].
    Riedl S; Lux T; Abel U; Theuer D
    Z Gastroenterol; 2005 Apr; 43(4):357-65. PubMed ID: 15830301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoguided surgery in recurrent colorectal cancer: the role of carcinoembryonic antigen, computerized tomography, and physical examination.
    Sardi A; Agnone CM; Nieroda CA; Mojzisik C; Hinkle G; Ferrara P; Farrar WB; Bolton J; Thurston MO; Martin EW
    South Med J; 1989 Oct; 82(10):1235-44. PubMed ID: 2799440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs.
    Kawamura YJ; Tokumitsu A; Mizokami K; Sasaki J; Tsujinaka S; Konishi F
    Clin Colorectal Cancer; 2010 Jan; 9(1):48-51. PubMed ID: 20100688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.
    Titu LV; Nicholson AA; Hartley JE; Breen DJ; Monson JR
    Ann Surg; 2006 Mar; 243(3):348-52. PubMed ID: 16495699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
    Grossmann I; de Bock GH; Meershoek-Klein Kranenbarg WM; van de Velde CJ; Wiggers T
    Eur J Surg Oncol; 2007 Mar; 33(2):183-7. PubMed ID: 17174516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum tumor antigen CA19-9 after curative resection of colorectal cancer.
    Park IJ; Choi GS; Jun SH
    Anticancer Res; 2009 Oct; 29(10):4303-8. PubMed ID: 19846991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
    Sawabata N; Maeda H; Yokota S; Takeda S; Koma M; Tokunaga T; Ito M
    Cancer; 2004 Aug; 101(4):803-9. PubMed ID: 15305413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study.
    Hara M; Kanemitsu Y; Hirai T; Komori K; Kato T
    Dis Colon Rectum; 2008 Nov; 51(11):1675-80. PubMed ID: 18633674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raised carcinoembryonic antigen level as an indicator of recurrent disease in follow up of patients with colorectal cancer.
    Miles WF; Greig JD; Seth J; Sturgeon C; Nixon SJ
    Br J Gen Pract; 1995 Jun; 45(395):287-8. PubMed ID: 7619581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.